Additional Proxy Soliciting Materials (definitive) (defa14a)
May 12 2023 - 1:35PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ Preliminary Proxy Statement
☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐ Definitive Proxy Statement
☒ Definitive Additional Materials
☐ Soliciting Material Pursuant to §240.14a-12
Mind Medicine (MindMed) Inc.
(Name of Registrant as Specified In Its Charter)
N/A
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
☒ No fee required
☐ Fee paid previously with preliminary materials
☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
On May 15, 2023, Mind Medicine (MindMed) Inc. (the “Company”) distributed a letter to shareholders in connection with the Company’s 2023 Annual General Meeting of Shareholders. A copy of the letter can be found below.:
__________________________________________________________________________________________________________
Mind Medicine MindMed (NASDAQ:MNMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mind Medicine MindMed (NASDAQ:MNMD)
Historical Stock Chart
From Jul 2023 to Jul 2024